Loading...
Loading...
Analysts at Bank of America downgraded
Quest Diagnostics Inc.DGX from Neutral to Underperform.
Quest Diagnostics shares have gained 33.38% over the past 52 weeks, while the S&P 500 index has surged 14.22% in the same period.
Quest Diagnostics' shares surged 0.45% to close at $71.77 on Friday
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in